Viewing Study NCT00762892

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:31 PM
Ignite Modification Date: 2025-12-27 @ 7:04 PM
Study NCT ID: NCT00762892
Status: COMPLETED
Last Update Posted: 2015-01-05
First Post: 2008-09-26
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Raltegravir vs. Atazanavir in Combination With Truvada® for the Treatment of Antiretroviral naïve HIV Infected Patients
Sponsor: The University of Texas Health Science Center, Houston
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV Infections View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Raltegravir View
None Integrase inhibitor View
None Protease inhibitor View
None Naive patients View
None HIV disease View
None Lipids View
None Treatment Naïve View